Milestone Scientific Inc. (MLSS)
1.09
-0.08 (-6.84%)
At close: Feb 20, 2025, 3:59 PM
1.09
0.32%
After-hours: Feb 20, 2025, 06:30 PM EST
undefined% (undefined)
| Bid | 1 |
| Market Cap | 84.63M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.06 |
| PE Ratio (ttm) | -18.11 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.17 |
| Volume | 83,629 |
| Avg. Volume (20D) | 202,027 |
| Open | 1.21 |
| Previous Close | 1.17 |
| Day's Range | 1.08 - 1.21 |
| 52-Week Range | 0.54 - 1.39 |
| Beta | undefined |
About MLSS
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a ...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Nov 3, 1995
Employees 17
Stock Exchange AMEX
Ticker Symbol MLSS
Next Earnings Release
Milestone Scientific Inc. is scheduled to release its earnings on Mar 31, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+26.42%
Milestone Scientific shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago
+1.39%
Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 financials.
3 months ago · seekingalpha.com
Milestone Scientific Inc. (MLSS) Q3 2024 Earnings Call TranscriptMilestone Scientific Inc. (NYSE:MLSS ) Q3 2024 Earnings Call Transcript November 15, 2024 8:30 AM ET Company Participants David Waldman - Crescendo Communications, Investor Relations Arjan Haverhals -...